Electrical storm in patients with biventricular implantable cardioverter defibrillator: Incidence, predictors, and prognostic implications

American Heart Journal

Volumn 156, Issue 5, 2008, Pages 847-854

  Gasparini, Maurizio ^a   Lunati, Maurizio ^b   Landolina, Maurizio ^c   Santini, Massimo ^d   Padeletti, Luigi ^e   Perego, Gianni ^f   Vincenti, Antonio ^g   Curnis, Antonio ^h   Carboni, Angelo ⁱ   Denaro, Alessandra ^j   Spotti, Alessia ^j   Grammatico, Andrea ^j   Regoli, François ^a   Boriani, Giuseppe ^k  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f S Luca Hospital   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h Cardiology Department   (Italy)

ⁱ MAGGIORE HOSPITAL   (Italy)

^j Clinical Department   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; PROGNOSIS; TACHYCARDIA, VENTRICULAR;

EID: 54849431571     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.06.035     Document Type: Article

References (32)

1. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
3. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
4. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1940-1993
5. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death among patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
6. Moss A.J., Fadl Y., Zareba W., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
7. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
8. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
9. Villacastin J., Almendral J., Arenal A., et al. Incidence and clinical significance of multiple consecutive, appropriate, high energy discharges in patients with implanted cardioverter-defibrillators. Circulation 93 (1996) 753-762
10. Credner S.C., Klingenheben T., Mauss O., et al. Electrical storm in patients with transvenous implantable cardioverter-defibrillators. Incidence, management and prognostic implications. J Am Coll Cardiol 32 (1998) 1909-1915
11. Exner D.V., Pinski S.L., Wyse G., et al. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Circulation 103 (2001) 2066-2071
12. Verma A., Kilicaslan F., Marrouche N.F., et al. Prevalence, predictors and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 15 (2004) 1265-1270
13. Hohnloser S.H., Al-Khalidi H.R., Pratt C.M., et al. Electrical storm in patients with implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 27 (2006) 3027-3032
14. Gatzoulis K.A., Andrikopoulos G.K., Apostolopoulos T., et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7 (2005) 184-192
15. Arya A., Haghjoo M., Dehghani M.R., et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol 97 (2006) 389-392
16. Ricci R., Ansalone G., and Toscano S. Cardiac resynchronization: materials, technique and results. The InSync Italian Registry. Eur Heart J 2 (2000) J6-J15
17. Sweeney M.O., Wathen M.S., Volosin K., et al. Appropriate and inappropriate ventricular therapies, quality of life and mortality among primary and secondary prevention implantable cardioverter defibrillator patients. Circulation 111 (2005) 2898-2905
18. Wilkoff B.L., Hess M., Young J., et al. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 15 (2004) 1002-1009
19. Gasparini M., Lunati M., Bocchiardo M., et al. Cardiac resynchronization and implantable cardioverter defibrillator therapy: preliminary results from the InSync implantable cardioverter defibrillator Italian registry. Pacing Clin Electrophysiol 26 Pt. II (2003) 148-151
20. Hurwitz J.L., Hook B.G., Flores B.T., et al. Importance of abortive shock capability with electrogram storage cardioverter-defibrillator devices. J Am Coll Cardiol 21 (1993) 895-900
21. Hook B.G., Callans D.J., Kleinman R.B., et al. Implantable cardioverter defibrillator therapy in the absence of significant symptoms. J Am Coll Cardiol 21 (1993) 895-900
22. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743
23. Cleland J.G.F., Daubert J.C., Erdmann E., et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CARE-HF extension trial]. Eur Heart J 27 (2006) 1928-1932
24. Boriani G., Gasparini M., Lunati M., et al. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. Am Heart J 152 (2006) 527.e1-527.e11
25. Roberts W.C., Siegel R.J., and McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60 (1987) 1304-1315
26. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
27. Delacretaz E., Stevenson W.G., Ellison K.E., et al. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in non-ischemic heart disease. J Cardiovasc Electrophysiol 11 (2000) 11-17
28. Brigadeau F., Kouakam C., Klug D., et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 27 (2006) 700-707
29. Saxon L.A., Bristow M.R., Boehmer J., et al. Predictors of sudden cardiac death and appropriate shock in Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 114 (2006) 2766-2772
30. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of b-blockers, amiodarone plus b-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. The OPTIC study: a randomized trial. JAMA 295 (2006) 165-171
31. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357 (2007) 2657-2665
32. Lainscak M., Cleland J.G., Lenzen M.J., et al. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 9 (2007) 292-299